Robinson Pharma Opens 10th US Facility as Contract Manufacturing Demand Grows

Robinson Pharma, a contract manufacturer of dietary supplements, has opened a new facility in Irvine, California, its 10th warehouse location and an expansion that adds 260,000 square feet to the company's total production space.¹

The company describes the addition as intended to increase production volume and improve operational efficiency across its existing service lines, which include softgels, capsules, tablets, powders, and liquid formulations.

Why Are Contract Manufacturers Expanding Capacity Right Now?

Capacity expansions like this one reflect a broader industry pattern: dietary supplement brands have increasingly outsourced formulation, encapsulation, and packaging rather than building manufacturing infrastructure internally.

According to one industry analysis, the global dietary supplement contract manufacturing market was estimated at $25.4 billion in this year and is projected to reach $58.9 billion by 2033, a compound annual growth rate of roughly 12.8%.²

That growth has been driven in part by newer and smaller brands seeking to enter the market without the capital investment required to build proprietary manufacturing lines, alongside established brands looking to scale production of newer formats like gummies and vegetarian softgels. The same analysis notes that contract manufacturers are increasingly pursuing partnerships, collaborations, and acquisitions of their own as they compete to expand geographic reach and service offerings.

What Does This Facility Actually Add to Robinson Pharma's Operations?

The Irvine facility expands Robinson Pharma's capacity across the same dosage formats the company already produces elsewhere, rather than introducing a new manufacturing category. The company holds FDA registration alongside third-party good manufacturing practice certifications, including NSF GRMA, UL GMP, SQF, CCOF, and SCCI, credentials that function as a baseline expectation for brands vetting a contract manufacturing partner rather than a differentiating claim on their own.

For manufacturers evaluating contract manufacturing partners generally, facility certifications indicate that a supplier meets recognized quality system standards, but they do not by themselves confirm capacity availability, lead times, or minimum order requirements, details that typically require direct inquiry with the manufacturer.

How Should Brands Evaluate a Contract Manufacturer's Capacity Claims?

Announcements describing expanded square footage or new facility locations provide a general signal of a manufacturer's scale, but they don't necessarily translate into immediately available capacity for a new brand partner. Manufacturers researching contract manufacturing options should request specific information on current production lead times, minimum order quantities, and formulation capabilities for their specific dosage format, since a facility's total square footage does not indicate how much of that capacity is already allocated to existing client contracts.

Brands should also confirm whether a facility's certifications apply company-wide or to specific production lines only, since a manufacturer's overall accreditation does not always extend uniformly across every location or dosage format it offers.

What Remains Unclear About This Expansion?

The press release does not disclose the facility's production capacity in units or batches, a timeline for when the new location will reach full operational output, or whether the expansion is tied to specific new client commitments or anticipated demand based on broader industry growth. It also does not specify how many employees the new facility will add or whether it introduces any new dosage formats beyond those Robinson Pharma already manufactures at its other nine locations.

References

1. Robinson Pharma announces major expansion with new facility in Irvine, California. Robinson Pharma. August 3, 2026. Accessed August 6, 2026. https://www.prnewswire.com/news-releases/robinson-pharma-announces-major-expansion-with-new-facility-in-irvine-california-302841696.html

2. Dietary supplements contract manufacturing market report (2026-2033). Grand View Research. August 2026. Accessed August 6, 2026. https://www.grandviewresearch.com/industry-analysis/dietary-supplement-contract-manufacturing-market-report